We are live on ! Find out more
IACGFIA

IDG-Accel China Growth Fund III Associates Portfolio holdings

AUM $31.2M
1-Year Est. Return 2.97%
This Fund
S&P 500
This Quarter Est. Return
+82.96%
1 Year Est. Return
-2.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$86.6M
AUM Growth
+$31.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 45.15%
2 Healthcare 32.86%
3 Consumer Discretionary 16.42%
4 Consumer Staples 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JG
1
Aurora Mobile
JG
$29.8M
$39.1M 45.15%
548,909
CASI
2
DELISTED
CASI Pharmaceuticals
CASI
$23.5M 27.18%
797,354
SECO
3
DELISTED
Secoo Holding Limited ADR
SECO
$9.62M 11.11%
418,270
AIH
4
DELISTED
Aesthetic Medical International Holdings
AIH
$4.92M 5.69%
933,800
LAIX
5
DELISTED
LAIX Inc. American Depositary Shares, each representing fourteen Class A Ordinary Shares
LAIX
$4.82M 5.57%
226,414
MOGU
6
MOGU Inc
MOGU
$15.3M
$4.59M 5.3%
176,187

Similar funds

IDG-Accel China Growth Fund III Associates's Q4 2020 Portfolio in Review

As of Q4 2020, IDG-Accel China Growth Fund III Associates held 6 positions worth $86.6M, up 57% from $55M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 0%. IDG-Accel China Growth Fund III Associates opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • IDG-Accel China Growth Fund III Associates's ten largest holdings make up 100% of its $86.6M portfolio in Q4 2020.
  • IDG-Accel China Growth Fund III Associates opened 0 new positions and closed 0 in Q4 2020.
  • IDG-Accel China Growth Fund III Associates's portfolio value rose 57% quarter-over-quarter to $86.6M.

Based on IDG-Accel China Growth Fund III Associates's 13F filing for Q4 2020, filed 12 Feb 2021.